Published in J Cancer Res Clin Oncol on September 26, 2003
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol (2011) 1.13
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53. Biochem Pharmacol (2011) 1.03
Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21. Br J Cancer (2006) 0.96
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate. Bioorg Med Chem Lett (2011) 0.87
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells. Medchemcomm (2012) 0.83
The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis. DNA Cell Biol (2009) 0.83
Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. Br J Cancer (2007) 0.81
Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53. Oncogene (2016) 0.77
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner. Cancer Chemother Pharmacol (2009) 0.77
Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells. Oncotarget (2016) 0.75
Cancer. p53, guardian of the genome. Nature (1992) 16.36
Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90
Cell cycle control and cancer. Science (1994) 10.90
Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell (1997) 10.52
Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A (1992) 8.87
Signaling to p53: breaking the MDM2-p53 circuit. Cell (1998) 8.63
The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev (1998) 7.46
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol (2001) 7.26
A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev (1999) 6.34
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (1996) 6.11
Tumor suppressor genes. Science (1991) 5.72
Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem (2001) 5.43
ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet (1998) 3.66
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene (1993) 3.43
Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol (1990) 3.30
Regulation of p53 in response to DNA damage. Oncogene (1999) 3.23
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A (1992) 3.22
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol (2002) 3.08
Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J (1999) 3.00
Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res (1995) 2.89
The role of DNA mismatch repair in platinum drug resistance. Cancer Res (1996) 2.88
Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res (1985) 2.50
Activation of the p53 tumor suppressor protein. Biochim Biophys Acta (2002) 2.44
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells (1990) 2.43
The cellular response to p53: the decision between life and death. Oncogene (1999) 2.31
Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A (1998) 2.11
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res (1995) 2.00
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry (1988) 1.76
Multisite phosphorylation and the integration of stress signals at p53. Cell Signal (1998) 1.73
Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc Natl Acad Sci U S A (1998) 1.70
Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin Cancer Res (1997) 1.62
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res (1997) 1.39
The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res (2000) 1.27
Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide. Anal Biochem (1987) 1.22
Covalent and noncovalent modifiers of the p53 protein. Cell Mol Life Sci (1999) 1.17
The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res (1996) 1.16
Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene (1997) 1.12
Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res (1993) 1.11
The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett (2000) 1.09
Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol (1999) 1.09
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Clin Cancer Res (1999) 1.08
Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene (2000) 1.07
Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. Cancer Res (1998) 1.05
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. Br J Cancer (1995) 0.99
Resistance to platinum compounds: mechanisms and beyond. Eur J Cancer Clin Oncol (1989) 0.93
ATM dependent apoptosis in the nervous system. Apoptosis (2000) 0.90
p53 gene status and chemosensitivity in ovarian cancer. Hum Cell (2001) 0.90
Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance. J Inorg Biochem (1999) 0.85
Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane. J Med Chem (1987) 0.84
The biology of ovarian cancer. Curr Opin Oncol (1993) 0.80
DNA Damage Induces p53-dependent Down-regulation of hCHK1. J Biol Chem (2001) 0.77
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res (2009) 2.17
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab. Cancer Res (2007) 2.14
Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol (2007) 2.12
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem (2003) 1.95
Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther (2004) 1.82
Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin Cancer Res (2009) 1.61
Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer (2012) 1.55
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene (2005) 1.43
Neural correlates of fine depth discrimination in monkey inferior temporal cortex. J Neurosci (2005) 1.41
Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976) (2013) 1.38
MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol (2012) 1.35
Absolute stereochemistry of citrinadins a and B from marine-derived fungus. J Org Chem (2005) 1.34
PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clin Cancer Res (2013) 1.31
CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res (2012) 1.31
Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford) (2011) 1.21
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog. Gynecol Oncol (2011) 1.13
Tissue platinum concentration and tumor response in non-small-cell lung cancer. J Clin Oncol (2012) 1.11
Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study. Spine (Phila Pa 1976) (2012) 1.09
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1. Mol Pharmacol (2008) 1.09
Existence of a neuropathic pain component in patients with osteoarthritis of the knee. Yonsei Med J (2012) 1.08
Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J Surg Oncol (2012) 1.07
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer. Ann Surg Oncol (2015) 1.04
Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol (2013) 1.04
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53. Biochem Pharmacol (2011) 1.03
Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol (2009) 1.03
CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncol Rep (2013) 1.03
Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma. Ann Surg Oncol (2010) 1.02
Single-level instrumented posterolateral fusion of the lumbar spine with a local bone graft versus an iliac crest bone graft: a prospective, randomized study with a 2-year follow-up. Eur Spine J (2010) 1.02
Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma. Anticancer Res (2011) 1.02
Executive impairment in Parkinson's disease: response automaticity and task switching. Neuropsychologia (2010) 1.02
LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history. Ann Surg Oncol (2012) 1.02
The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway. Int J Cancer (2014) 1.00
Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma. Ann Surg Oncol (2011) 1.00
Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection. Dis Colon Rectum (2015) 1.00
Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine (Phila Pa 1976) (2012) 0.98
Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep (2003) 0.97
Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today (2013) 0.97
Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling. Oncol Lett (2012) 0.96
Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB (Oxford) (2006) 0.96
KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review. Ann Surg Oncol (2012) 0.96
LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer (2012) 0.95
LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Ann Surg (2013) 0.95
Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J (2012) 0.95
CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci (2013) 0.94
A case of symptomatic extra-foraminal lumbosacral stenosis ("far-out syndrome") diagnosed by diffusion tensor imaging. Spine (Phila Pa 1976) (2012) 0.94
Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. Carcinogenesis (2013) 0.94
Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci (2009) 0.93
Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer. Cancer Res (2013) 0.93
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells. J Natl Cancer Inst (2011) 0.92
Review of the alterations in DNA methylation in esophageal squamous cell carcinoma. Surg Today (2013) 0.92
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. Oncology (2009) 0.92
Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa. J Gastroenterol (2014) 0.91
Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival. Ann Surg Oncol (2014) 0.91
LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma. Clin Cancer Res (2014) 0.90
Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. J Inorg Biochem (2005) 0.90
Evaluation of behavior and neuropeptide markers of pain in a simple, sciatic nerve-pinch pain model in rats. Eur Spine J (2010) 0.90
[A case of poorly differentiated lung adenocarcinoma showing air-space consolidation caused by aerogenic metastasis]. Nihon Kokyuki Gakkai Zasshi (2004) 0.90
Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer. PLoS One (2013) 0.90
p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma. Med Oncol (2013) 0.90
The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab. Ann Surg Oncol (2013) 0.90
ATP11B mediates platinum resistance in ovarian cancer. J Clin Invest (2013) 0.88
Surgical versus nonsurgical treatment of selected patients with discogenic low back pain: a small-sized randomized trial. Spine (Phila Pa 1976) (2011) 0.88
Proinflammatory cytokines in the cerebrospinal fluid of patients with lumbar radiculopathy. Eur Spine J (2010) 0.88
The incidence of alcohol-associated osteonecrosis of the knee is lower than the incidence of steroid-associated osteonecrosis of the knee: an MRI study. Rheumatology (Oxford) (2011) 0.88
Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer. Surg Today (2013) 0.87
English publication rate of 3,205 abstracts presented at the Annual Meeting of the Japanese Orthopaedic Association and the Annual Research Meeting of the Japanese Orthopaedic Association. J Orthop Sci (2013) 0.87
p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors. Oncology (2002) 0.87
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines. Dalton Trans (2009) 0.87
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate. Bioorg Med Chem Lett (2011) 0.87
Genetic mutual relationship between PTEN and p53 in gastric cancer. Cancer Lett (2005) 0.87
Fascia lata onlay patch for repairing infected incisional hernias. Surg Today (2014) 0.87
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer. Oncol Rep (2006) 0.87
Pancreatic cancer in the remnant pancreas following primary pancreatic resection. Surg Today (2013) 0.87
Drehmann sign and femoro-acetabular impingement in SCFE. J Pediatr Orthop (2011) 0.86
Lumbar disc degeneration induces persistent groin pain. Spine (Phila Pa 1976) (2012) 0.86
Complications of percutaneously inserted central venous catheters in Japanese neonates. Pediatr Int (2008) 0.86
Giant liposarcoma of the posterior mediastinum and retroperitoneum. BMJ Case Rep (2011) 0.86
Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer. Surg Today (2014) 0.86
Threshold mechanism for saccade initiation in frontal eye field and superior colliculus. J Neurophysiol (2013) 0.85
Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma. J Surg Oncol (2011) 0.85
Role of the basal ganglia in switching a planned response. Eur J Neurosci (2009) 0.85
Sensory innervation and inflammatory cytokines in hypertrophic synovia associated with pain transmission in osteoarthritis of the hip: a case-control study. Rheumatology (Oxford) (2012) 0.85
Degeneration and recovery of the neuromuscular junction after application of extracorporeal shock wave therapy. J Orthop Res (2012) 0.85
Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer. Ann Surg Oncol (2014) 0.85
Low back pain after lumbar discectomy in patients showing endplate modic type 1 change. Spine (Phila Pa 1976) (2010) 0.84
Modification of the luminescence spectra of chloro(tetrapyridylcyclotetramine)europium complexes by fine tuning of the Eu-Cl distance with outer-sphere counterions in the solid state, in a polymer matrix and in solution. Chem Commun (Camb) (2008) 0.84
Delayed surgical treatment for a traumatic bilateral cervical facet joint dislocation using a posterior-anterior approach: a case report. J Med Case Rep (2013) 0.84
Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer. Int J Clin Oncol (2010) 0.84
Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. J Clin Neurosci (2009) 0.83
Rank classification based on the combination of indocyanine green retention rate at 15 min and (99m)Tc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection. Nucl Med Commun (2014) 0.83
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells. Medchemcomm (2012) 0.83
Single-level instrumented posterolateral fusion versus non-instrumented anterior interbody fusion for lumbar spondylolisthesis: a prospective study with a 2-year follow-up. J Orthop Sci (2011) 0.83
One, two-, and three-level instrumented posterolateral fusion of the lumbar spine with a local bone graft: a prospective study with a 2-year follow-up. Spine (Phila Pa 1976) (2011) 0.83
Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog. Prostate (2005) 0.83
The relation of alcohol consumption and cigarette smoking to the multiple occurrence of esophageal dysplasia and squamous cell carcinoma. Surgery (2002) 0.83
Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients. Int J Clin Oncol (2012) 0.83